Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACRS | AVTX | ALDX | ||
| Company | Aclaris Therapts | Avalo Therapeutics Inc | Aldeyra Therapeu | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.03 | 20.00 | 5.27 | ||
| High | 3.14 | 20.12 | 5.68 | ||
| Low | 3.03 | 18.80 | 5.00 | ||
| Latest | 3.08 | 18.91 | 5.01 | ||
| Change | +0.05 | -0.34 | -0.24 | ||
| % Change | +1.65% | -1.77% | -4.57% | ||
| Volume | 683,200 | 758,500 | 1,768,100 | ||
| 20-Day Average Volume | 1,288,695 | 325,605 | 1,626,690 | ||
| Previous Close | 3.03 | 19.25 | 5.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 2.95 | 18.33 | 4.95 | ||
| 20-Day Raw Stochastic | 65.14% | 65.13% | 61.49% | ||
| 20-Day Relative Strength | 58.78 | 56.12 | 50.16 | ||
| Weighted Alpha | +52.06 | +175.78 | +155.76 | ||
| Today's Opinion | 100% Buy | 100% Buy | 16% Buy | ||
| Previous Opinion | 100% Buy | 100% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.33% since 12/11/25 | -3.08% since 12/11/25 | +9.15% since 12/11/25 | ||
| Low | 3.03 on 12/18/25 | 17.18 on 12/16/25 | 3.94 on 12/16/25 | ||
| High | 3.41 on 12/12/25 | 20.28 on 12/15/25 | 5.68 on 12/18/25 | ||
| 1-Month | |||||
| %Chg | +23.69% since 11/18/25 | +5.06% since 11/18/25 | +2.04% since 11/18/25 | ||
| Low | 2.34 on 11/21/25 | 15.53 on 12/03/25 | 3.94 on 12/16/25 | ||
| High | 3.47 on 12/11/25 | 20.72 on 12/11/25 | 5.68 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +57.95% since 09/18/25 | +59.18% since 09/18/25 | unch since 09/18/25 | ||
| Low | 1.74 on 10/14/25 | 10.70 on 09/26/25 | 3.94 on 12/16/25 | ||
| High | 3.47 on 12/11/25 | 20.72 on 12/11/25 | 5.79 on 10/16/25 | ||
| 6-Month | |||||
| %Chg | +116.90% since 06/18/25 | +297.27% since 06/18/25 | +58.04% since 06/18/25 | ||
| Low | 1.34 on 06/23/25 | 4.50 on 06/25/25 | 2.95 on 06/23/25 | ||
| High | 3.47 on 12/11/25 | 20.72 on 12/11/25 | 6.18 on 08/28/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 328,285 | 349,080 | 315,856 | ||
| Shares Outstanding, K | 108,345 | 18,134 | 60,163 | ||
| Annual Sales | 18,720,000 | 440,000 | 0 | ||
| Annual Net Income | -132,070,000 | -35,130,000 | -55,850,000 | ||
| Last Quarter Sales | 3,300,000 | 0 | 0 | ||
| Last Quarter Net Income | -14,610,000 | -30,630,000 | -7,690,000 | ||
| 60-Month Beta | 0.62 | 0.84 | 0.83 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 11/06/25 | -2.19 on 11/06/25 | -0.13 on 11/05/25 | ||
| Latest Earnings Date | 02/26/26 | 03/19/26 | 02/27/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||